ABBOTT LABORATORIES
ABBOTT LABORATORIES (ABT): 991 pipeline candidates · ~9 mo cash runway · 24 clinical trials. Updated within the last hour.
BioSniper Score
3-factor signal · derived from public data
8.5 months
N/A
N/A
991 candidates
N/A
5 buys · 6 sells (180d)
A transparent, data-derived signal for ABBOTT LABORATORIESacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$149.1B
Cash
$6.8B
Quarterly Burn
$4.5B
Runway
8.5 mo
Revenue
$11.2B
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (991 candidates)
Showing 10 of 991 candidates. Sign up for full pipeline.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
3,070
Total value held
$141.93B
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 225,899,866 | $23.19B |
| blackrock, inc. | 145,793,958 | $14.97B |
| state street corp | 79,575,468 | $8.17B |
| vanguard portfolio management llc | 47,944,891 | $4.92B |
| charles schwab investment management inc | 45,500,055 | $4.67B |
| geode capital management, llc | 39,148,795 | $4.00B |
| morgan stanley | 30,101,596 | $3.09B |
| wellington management group llp | 27,070,518 | $2.78B |
| jpmorgan chase & co | 26,767,099 | $2.73B |
| franklin resources inc | 20,022,905 | $2.06B |
Showing top 10 of 3,070 institutional holders of ABBOTT LABORATORIES. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in ABBOTT LABORATORIES's pipeline?
ABBOTT LABORATORIES (ABT) has 991 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is ABBOTT LABORATORIES's cash runway?
Based on its most recent reported cash balance and quarterly burn rate, ABBOTT LABORATORIES has approximately 8.5 months of cash runway.
What is ABBOTT LABORATORIES's market capitalization?
ABBOTT LABORATORIES's market capitalization is approximately $149.1B.
Who is the CEO of ABBOTT LABORATORIES?
Mr. Robert B. Ford is the chief executive officer of ABBOTT LABORATORIES (ABT).
Get the full picture on ABBOTT LABORATORIES
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.